Why Participate in a Clinical Trial?

Phase I trials are the cornerstone for advancement of new therapies. A Phase I trial represents the clinical starting point for all new drugs that ultimately receive FDA approval and often represents the first time a drug or compound is being tested in humans.

A Phase I study is designed to test a potential anticancer compound that has shown promising results in the laboratory in a small population of cancer patients.

For researchers, the goal is to evaluate the compound’s overall safety, determine a safe dosage range, and identify side effects. It also allows researchers to study how the drug will act in the body and whether or not it gives benefit to patients.

For patients, participating in a Phase I clinical trial gives them access to some of the latest cancer treatments. Patients who go on these studies are true pioneers as their participation may lead to groundbreaking data that can ultimately lead to newer and better drugs for patients with advanced cancer.

Interested in learning more about the trials at START? Select a preferred START location to find out more.